AAX Biotech to showcase at BIO-Europe 2024 in Stockholm Sweden

AAX Biotech is excited to participate and showcase at BIO-Europe 2024 in Stockholm from 4th-6th November!

Meet our CEO Maria Lisa Knudsen to explore how we can leverage our unique technologies Seqitope™ and Opti-mAb™ to accelerate drug development and enable the development of next-generation antibody therapeutics that are more efficient and have higher developability.

We are proud to join the Swedish Pavilion 🇸🇪, a hub for Sweden’s top life sciences startups. Stop by for round-table discussions and presentations, and connect with us here to discuss how we can push forward drug development.

Previous
Previous

AAX Biotech to present at PEGS Europe 2024 in Barcelona, Spain

Next
Next

AAX Biotech Secures Funding to Drive Technology Development and Expansion